These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15985295

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial.
    Nickel C, Tritt K, Muehlbacher M, Pedrosa Gil F, Mitterlehner FO, Kaplan P, Lahmann C, Leiberich PK, Krawczyk J, Kettler C, Rother WK, Loew TH, Nickel MK.
    Int J Eat Disord; 2005 Dec; 38(4):295-300. PubMed ID: 16231337
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up.
    Nickel MK, Loew TH.
    Eur Psychiatry; 2008 Mar; 23(2):115-7. PubMed ID: 18024088
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.
    Headache; 2007 Mar; 47(10):1398-408. PubMed ID: 18052949
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 14. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 15. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
    Roy Chengappa K, Kupfer DJ, Parepally H, John V, Basu R, Buttenfield J, Schlicht P, Houck P, Brar JS, Gershon S.
    Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 17. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [Abstract] [Full Text] [Related]

  • 18. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
    Kushner SF, Khan A, Lane R, Olson WH.
    Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
    [Abstract] [Full Text] [Related]

  • 19. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.
    Connor GS, Edwards K, Tarsy D.
    Clin Neuropharmacol; 2008 Feb; 31(2):97-103. PubMed ID: 18382182
    [Abstract] [Full Text] [Related]

  • 20. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.